期刊文献+

伏立康唑/羟丙基倍他环糊精包合物的制备及性质考察 被引量:6

The preparation and property investigation of voriconazole and HP-β-CD inclusion complex
下载PDF
导出
摘要 目的选用羟丙基倍他环糊精(HP-β-CD)对难溶性药物伏立康唑进行包合,以期提高其溶出速率,并对包合过程进行研究。方法采用研磨法、超声法、溶液搅拌法制备伏立康唑包合物。通过差示扫描量热法和X射线粉末衍射法,考察伏立康唑/HP-β-CD包合物形成特征。比较pH值为1.0、4.0、7.0条件下,HP-β-CD对伏立康唑的增溶能力并与磺丁基醚倍他环糊精(SBE-β-CD)进行比较。最后考察包合过程中pH值、温度及潜溶剂等因素对溶解度相图的影响。结果以溶液搅拌法制备伏立康唑包合物,当包合温度为25℃,pH值为6.0,不加潜溶剂,以及药物与HP-β-CD的投料质量比为1∶12时,伏立康唑/HP-β-CD包合物形成的ΔH、ΔG和ΔS分别为-36.85、-13.63和-77.90。结论研究制备的伏立康唑/HP-β-CD包合物,性质稳定,包合量可以达到临床用药剂量的要求,包合过程中得到的相关热力学参数,为包合条件的优化提供理论依据。 Objective To improve the solubility of a poorly water-soluble drug-voriconazole,HP-β-CD is used as inclusion materials to prepare voriconazole/HP-β-CD complexes and to study the process of inclusion.Methods Voriconazole/HP-β-CD complexes were prepared by milling method,ultrasound method and unsaturated agitating method respectively.Differential scanning calorimetry(DSC) and X-ray diffractometry(XRD) were applied to characterize the voriconazole /HP-β-CD complex.The solubility enhancement effect of HP-β-CD and SBE-β-CD on voriconazole was compared at pH 1.0,pH 4.0 and pH 7.0.At last,the apparent stability constant at different pH,temperature and addition of cosolvent were counted,respectively.Results The unsaturated agitating method was feasible for the preparing of voriconazole/HP-β-CD complex.When in the condition of 25 ℃,pH 6.0,without addition of cosolvent and the ratio of voriconazole and HP-β-CD was 1∶ 12,the ΔH,ΔG and ΔS of voriconazole/HP-β-CD inclusion complex were-36.85,-13.63and-77.90.Conclusions The voriconazole/HP-β-CD inclusion complex has a good stability and the inclusion content can reach the requirements of clinical dosage.The obtained thermodynamic parameters can provide theory basis for the optimization of inclusion.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2015年第5期331-335,342,共6页 Journal of Shenyang Pharmaceutical University
关键词 伏立康唑 羟丙基倍他环糊精 包合物 voriconazole HP-β-CD inclusion
  • 相关文献

参考文献12

  • 1DENNING D W, RIBAUD P, M1LPIED N, et al. Effi- cacy and safety of voriconazole in the treatment of a- cute invasive aspergillosis ~ J ]. Clinical Infectious Dis- ease ,2002,34:563 - 571.
  • 2LOUIS D, SARAVOLATZ L B, JOHNSONL C A, et al. Voriconazole : A new triazole antifungal agent ~ J ]. Clinical Infectious Disease,2003,36:630-637.
  • 3THOMAS J, WALSH P P, WINSTON D J, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neu- tropenia and persistent fever [J]. The New England Journal of Medicine,2002,346:225 - 234.
  • 4NAGASE Y, HIRATA M, WADA K, et al. Improve- ment of some pharmaceutical properties of DY-9760eby sulfobutyl ether/3-cyclodextrin [J]. Int J Pharm, 2001,229 : 163 - 172.
  • 5刘鄂湖,蔡光明,夏新华,熊晗辉,朱海升.羟丙基-β-环糊精增溶难溶性药物研究进展[J].中国药业,2007,16(8):25-27. 被引量:12
  • 6罗恒,赵燕宜,杨明.羟丙基-β-环糊精作为注射给药的载体研究进展[J].湖北中医学院学报,2007,9(3):68-70. 被引量:6
  • 7HOLVOET C,HEYDEN Y V, VERCAMMEN J P. Inclusion complexation of diazepam with different cy- clodextrins in formulations for parenteraluse[J]. Pharmazie ,2005,60 : 598 - 603.
  • 8葛竹兴,张小华.甲砜霉素-羟丙基-β-环糊精包合物的制备和鉴定[J].南京师大学报(自然科学版),2008,31(4):74-79. 被引量:6
  • 9陈国广,陈振华,刘伯成,李学明,韦萍.羟丙基-β-环糊精对黄芪甲苷包合作用的研究[J].时珍国医国药,2007,18(6):1457-1458. 被引量:7
  • 10ASBAHR A C, FRANCO L, BARISON A, et al. Bina- ry and ternary inclusion complexes of finasteride in HP-/3-CD and polymers:Preparation and characteriza- tion [J]- Bioorganic and Medicinal Chemistry, 2009, 17:2718 - 2723.

二级参考文献53

共引文献27

同被引文献60

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部